science wire

MHH Dean of Academic Career Development advocates targeted further development of structured support programmes for researching doctors.

A joint project of MHH and TK Niedersachsen is being implemented nationwide. Biliary atresia is a rare condition, but it can have serious consequences even in the first weeks of a child's life.

A clinical trial under MHH leadership is testing a new therapy with immune cells against the JC virus.

What framework conditions do children and young people need for good psychosocial development? This is what the MHH and the University of Hildesheim want to find out in a study.

MHH Cardiology participates in a nationwide project to improve risk assessment thanks to structured and standardized data.

People born deaf use parts of the auditory brain area for vision. However, this does not hinder the recovery of the sense of hearing, MHH researchers found. Humans have five senses to perceive their environment: Sight, hearing, touch, smell and taste. If a person loses one of these, the remaining senses partially compensate for the loss.

The MHH is looking for subjects with an IDH1 gene mutation for a multicenter study on the combination therapy of two drugs previously used individually against acute myeloid leukemia (AML) 28.

The multicentre ChangePDD project compares the effectiveness of two different therapies. MHH Psychiatry is involved and offers places for study participants.

In times of crisis, it is advantageous for people with rare diseases to receive care in highly specialized centers.

MHH admits 18 students via advance quota - Applications open in March via Lower Saxony's special-purpose association for the granting of approbation (NiZzA) 08.

Infections with the fungus Aspergillus fumigatus are difficult to fight - especially because the fungus forms a biofilm and can thus protect itself from antifungal drugs and the immune defence system.

MHH cardiology starts the multicentre ORION HF study. She wants to find out whether a preparation in tablet form can correct iron deficiency and alleviate the typical symptoms of heart failure.

The patients themselves choose between several treatment options. The aim of the project is to increase the quality of life and improve the success of treatment.

A research association led by the MHH is developing chip-based replacement and supplementary methods to avoid animal experiments. To this end, it is receiving 3.6 million euros in follow-up funding. Developing replacement and supplementary methods for animal experiments and thus avoiding animal testing is the goal of the "Micro-Replace Systems" research network led by André Bleich, Director of the Institute of Laboratory Animal Science at Hannover Medical School (MHH), and Maren von Köckritz-Blickwede from the Foundation of the University of Veterinary Medicine Hannover.

PAIN2.0 is an outpatient therapy program for people with recurrent pain. Participation is now possible.

Interdisciplinary team of heart surgeons and cardiologists has good experience with a prosthesis implanted via the apex of the heart The mitral valve is one of our four heart valves.

The facility offers innovative technology for the diagnosis and therapy of cardiac arrhythmias. A new treatment method is now available for patients with atrial fibrillation.

International expert committee led by Professor Arndt Vogel updates ESMO treatment guidelines for biliary tract cancer Biliary tract cancers (BTC) are cancers of the bile ducts and gallbladder.

MHH researcher Nico Lachmann receives 2.5 million euros for Fraunhofer-Attract group Immune cells and immune cell preparations are playing an increasingly important role in modern medicine&per

Kai Schmidt-Ott is increasingly focusing on single-cell sequencing and bioinformatics in his clinic. Whoever takes over a clinic management usually brings something with him: new ideas, research cooperation and proven staff. This is also true for Kai Schmidt-Ott, who took over the management of the Clinic for Renal and Hypertension Diseases six months ago.

Dr. Axel Schambach receives prestigious EU funding award for pioneering research on Usher syndrome Protecting children and adults from hereditary deafness with the help of gene therapy is one

Three professors of the Hannover Medical School are among the world's most cited researchers Three scientists from Hannover Medical School are among the most frequently cited researchers in the world: Professor Dr. Michael Manns, Professor Dr. Thomas Werfel and Thomas Thum. This was the result of an analysis of scientific publications by the company Clarivate Analytics.

DFG research group aims to elucidate the role of sialic acid as a regulator in developmental processes and diseases Sugar compounds from the glycan group play an important role in many biological processes in our body.

Research project iGUARD receives follow-up funding for the development of RNA-based drugs Despite successful vaccine development, there are still no effective drugs for most viral diseases.

At the Amyloidosis Centre Lower Saxony, MHH offers diagnostics and therapy to those affected by the disease Amyloidosis is a rare disease that can affect individual organs and body regions or the entire organism.

Cooperation between radiotherapy and cardiology: MHH experts achieve success with innovative treatment method Radiotherapy - most people think of it as the treatment of cancer.

International Lancet commission with MHH pneumologist Professor Dr Tobias Welte makes recommendations on prophylaxis, diagnosis and therapy Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease worldwide and the third leading cause of death.

MHH opens outpatient clinic to treat dysregulated sexuality in adolescents / Ministry of Social Affairs funds project with 300,000 euros Experts from the Department of Clinical Psychology and Sexual

MHH research team finds new AAV vectors for gene therapy in the heart muscle Gene therapies aim to cure severe, barely treatable monogentic diseases caused by a defect in a single gene.